Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Jul;80(1):9-19.
doi: 10.1053/j.ajkd.2021.12.012. Epub 2022 Feb 22.

Racial and Ethnic Disparities in Kidney Replacement Therapies Among Adults With Kidney Failure: An Observational Study of Variation by Patient Age

Affiliations
Observational Study

Racial and Ethnic Disparities in Kidney Replacement Therapies Among Adults With Kidney Failure: An Observational Study of Variation by Patient Age

Adam S Wilk et al. Am J Kidney Dis. 2022 Jul.

Abstract

Rationale & objective: Non-Hispanic Black and Hispanic patients present with kidney failure at younger ages than White patients. Younger patients are also more likely to receive transplants and home dialysis than in-center hemodialysis (ICHD), but it is unknown whether racial and ethnic disparities in treatment differ by age. We compared use of kidney replacement therapies between racial and ethnic groups among patients with incident kidney failure overall and by age.

Study design: Retrospective cohort study.

Setting & participants: 830,402 US adult (age >21 years) patients initiating kidney failure treatment during the period of 2011-2018.

Exposures: Patient race and ethnicity (non-Hispanic Black, non-Hispanic White, Hispanic, or other) and age group (22-44, 45-64, 65-74, or 75-99 years).

Outcome: Treatment modality (transplant, peritoneal dialysis [PD], home hemodialysis [HHD], or ICHD) as of day 90 of treatment.

Analytical approach: Differences in treatment modalities were quantified for patient subgroups defined by race and ethnicity and by age. Log-binomial regression models were fit to estimate adjusted risk ratios.

Results: 81% of patients were treated with ICHD, 3.0% underwent transplants (85% preemptive, 57% living-donor), 10.5% were treated with PD, and 0.7% were treated with HHD. Absolute disparities in treatment were most pronounced among patients aged 22-44 years. Compared with non-Hispanic White patients, whose percentages of treatment with transplant, PD, and HHD were 10.9%, 19.0%, and 1.2%, respectively, non-Hispanic Black patients were less commonly treated with each modality (unadjusted percentages, 1.8%, 13.8%, and 0.6%, respectively), as were Hispanic patients (4.4%, 16.9%, and 0.5%, respectively; all differences P < 0.001). After adjustment, the largest relative disparities were observed for transplant among the 22-44-year age group; compared with non-Hispanic White patients, the adjusted risk ratios for non-Hispanic Black and Hispanic patients were 0.21 (95% CI, 0.19-0.23) and 0.47 (95% CI, 0.43, 0.51), respectively.

Limitations: Race and ethnicity data not self-reported.

Conclusions: Among adults with incident kidney failure, racial and ethnic disparities in transplant and home dialysis use are most pronounced among the youngest adult patient age group.

Keywords: Kidney failure; RRT modality; access to care; age; end-stage renal disease (ESRD); health disparities; home dialysis; race/ethnicity; renal replacement therapy (RRT); social determinants of health; transplantation.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:. Unadjusted Risks of Transplantation (A), Peritoneal Dialysis (B), and Home Hemodialysis (C) by Race/ethnicity and Age, 2011–2018
Notes: Outcomes identified at 90 days after start of kidney failure treatment. NH = non-Hispanic, ICHD = in-center hemodialysis, PD = peritoneal dialysis, HHD = home hemodialysis. Transplantation at day 90 disproportionately comprises pre-emptive and living donor kidney transplants.

Comment in

References

    1. Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: Institute of Medicine (US) Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. National Academies Press, 2003. - PubMed
    1. United States Renal Data System (USRDS). 2020 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2020.
    1. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LYC, Held PJ, Port FK. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725–1730. doi:10.1056/NEJM199912023412303 - DOI - PubMed
    1. Evans RW, Manninen DL, Garrison LP Jr, Hart LG, Blagg CR, Gutman RA, Hull AR, Lowrie EG. The quality of life of patients with end-stage renal disease. N Engl J Med. 1985;312(9):553–559. doi:10.1056/NEJM198502283120905 - DOI - PubMed
    1. Simmons RG, Abress L. Quality-of-life issues for end-stage renal disease patients. Am J Kidney Dis. 1990;15(3):201–208. doi:10.1016/S0272-6386(12)80763-3 - DOI - PubMed

Publication types